Pathway Summary for SCN1A
Overview
SCN1A encodes the pore-forming α-subunit of Nav1.1, the most clinically important voltage-gated sodium channel in epilepsy genetics. Nav1.1 directly mediates the depolarizing phase of action potentials through voltage-dependent conformational switching that allows selective Na+ influx. The channel is particularly critical in GABAergic interneurons where it regulates inhibitory neuron excitability - loss-of-function mutations impair interneuron function leading to network hyperexcitability and seizures. SCN1A mutations cause >80% of Dravet syndrome cases.
Core Signaling Pathways
Action Potential Generation
Nav1.1 mediates the rapid depolarization phase of action potentials:
- Voltage sensing via S4 segments triggers channel opening
- Selective Na+ permeation through the pore domain
- Fast inactivation terminates Na+ influx
- Recovery from inactivation enables repetitive firing
GABAergic Interneuron Function
Nav1.1 is enriched in parvalbumin-positive interneurons where it:
- Enables high-frequency firing patterns
- Maintains inhibitory tone in neural circuits
- Supports feedforward and feedback inhibition
- Loss of function causes disinhibition and seizures
Axon Initial Segment Signaling
Nav1.1 concentrates at the axon initial segment (AIS) where it:
- Initiates action potentials
- Sets neuronal excitability threshold
- Integrates synaptic inputs
- Maintains AIS molecular organization
Pathway Diagram
Molecular Properties
- Voltage dependence: Activation ~-40 to -30 mV
- Ion selectivity: Na+ >> K+ (~10:1)
- Inactivation kinetics: Fast (<2 ms) and slow components
- Recovery time: 5-10 ms at -80 mV
Subcellular Localization
- Axon initial segment: Action potential initiation
- Nodes of Ranvier: Saltatory conduction
- Soma: Contributing to excitability
- Presynaptic terminals: Neurotransmitter release
Clinical Significance
Dravet Syndrome
- >80% caused by SCN1A mutations
- Severe myoclonic epilepsy of infancy
- Developmental delays and cognitive impairment
- Status epilepticus risk
GEFS+ (Genetic Epilepsy with Febrile Seizures Plus)
- Milder phenotype with febrile seizures
- Variable penetrance and expressivity
- Often missense mutations
Treatment Implications
- Contraindicated: Sodium channel blockers worsen seizures
- Beneficial: Drugs enhancing GABAergic function
- Precision medicine: Genotype-guided therapy
Regulatory Mechanisms
- β-subunits (SCN1B-4B): Modulate gating and trafficking
- FGF14: Regulates channel availability
- Ankyrin-G: AIS anchoring and clustering
- Phosphorylation: PKA/PKC modulation
- Temperature sensitivity: Enhanced dysfunction with fever
Functional Integration
- E/I balance: Critical for maintaining inhibitory tone
- Network oscillations: Supports gamma rhythms via interneurons
- Developmental regulation: Expression increases postnatally
- Compensation mechanisms: Other Nav channels partially compensate